Patent · US Active

KRAS G12C inhibitors and methods of using the same

US11096939B2 · kind B2 · utility

19Cited by
47References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2019
Grant dateAug 24, 2021
Priority date—
Expiry dateMay 31, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/2818
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are KRAS G12C inhibitors, such as

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.